“…6,43,49 Also, the contributing factor most frequently reported in the literature, active disease, was confirmed in the present study. 49,52,61,[63][64][65][66][67][68][69][70][71][72][73][74][75][76] Other factors described in the literature which unfavorably affect HRQoL in IBD were female gender 50,62,68,64 , corticosteroid 77,64,78 or immunosuppressive drug use, 78 hospitalization, 64 short bowel syndrome, 45,46 extraintestinal manifestations, 62,47,74,78 IBS-like symptoms, 60,79 and impaired coping behavior. [80][81][82][83] Factors positively influencing HRQoL in CD were use of immunosuppressives (after 1 year follow-up), 64 postsurgery situation, 50,84,85 adalimumab maintenance treatment (at week 56), 49 and having a partner …”